Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Khosla Ventures Acquisition Co. (KVSA : NSDQ)
 
 • Company Description   
Khosla Ventures Acquisition Co. entered into a definitive merger agreement with Valo Health LLC.

Number of Employees: 0

 
 • Price / Volume Information   
Yesterday's Closing Price: $9.76 Daily Weekly Monthly
20 Day Moving Average: 58,595 shares
Shares Outstanding: 35.49 (millions)
Market Capitalization: $346.38 (millions)
Beta: 0.07
52 Week High: $10.27
52 Week Low: $9.58
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.41% 12.16%
12 Week 0.21% 10.15%
Year To Date 0.62% 22.70%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2128 Sand Hill Road
-
Menlo Park,CA 94025
USA
ph: 650-376-8500
fax: -
None None
 
 • General Corporate Information   
Officers
Samir Kaul - Chief Executive Officer; President and Director
Peter Buckland - Chief Operating Officer; Chief Financial Officer;
Rajiv J. Shah - Director
Molly Coye - Director
Mario Schlosser - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 482504107
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 35.49
Most Recent Split Date: (:1)
Beta: 0.07
Market Capitalization: $346.38 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -0.75
12/31/21 - -1.64
09/30/21 - -
Current Ratio
03/31/22 - 0.16
12/31/21 - 0.21
09/30/21 - 0.50
Quick Ratio
03/31/22 - -
12/31/21 - 0.21
09/30/21 - 0.50
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -0.44
12/31/21 - -0.44
09/30/21 - -0.38
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©